Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEURIZER LTD Capital/Financing Update 2025

Feb 16, 2025

65442_rns_2025-02-16_eda5673c-bb75-4d6a-8bcf-a65a953bacfb.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [77 x 69] intentionally omitted <==

==> picture [449 x 35] intentionally omitted <==

ASX Announcement (ASX: NRZ)

17 February 2025

Private Share Placement

NeuRizer Ltd (the "Company") is pleased to advise that is has successfully completed a placement to raise $200,000 with a sophisticated investor (“the Placement”).

Placement Details

The Placement will result in the issue of 133,333,333 new fully paid ordinary shares at an issue price of $0.0015 per share to raise total proceeds of $200,000 (before costs).

The issuance of the new shares will be undertaken within the Company’s existing capacity under ASX Listing Rule 7.1A.

The Company confirms that no broker has been engaged for the Placement, and no broker fees are payable.

The funds raised from the Placement will be used for general working capital of the Company, enabling progress on the NeuRizer Urea Project.

The NeuRizer Board has authorised this announcement for release to the ASX.

Further Information

Investor Relations

Tony Lawry

T +61 412 467 160 E [email protected]

Level 5, 19 Grenfell Street Adelaide SA 5000 www.neurizer.com.au

==> picture [220 x 38] intentionally omitted <==